Profile data is unavailable for this security.
About the company
Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.
- Revenue in EUR (TTM)105.92m
- Net income in EUR19.10m
- Incorporated2001
- Employees246.00
- LocationRevenio Group OyjAyritie 22VANTAA 01510FinlandFIN
- Phone+358 987751150
- Fax+358 95865962
- Websitehttps://www.reveniogroup.fi/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellaVision AB | 66.11m | 13.45m | 380.75m | 228.00 | 28.32 | 5.14 | 22.43 | 5.76 | 6.38 | 6.38 | 31.36 | 35.16 | 0.7413 | 1.95 | 7.58 | 3,169,233.00 | 15.08 | 14.59 | 17.12 | 17.10 | 68.48 | 68.05 | 20.34 | 19.64 | 2.68 | 40.33 | 0.0267 | 38.49 | 6.78 | 9.39 | 7.99 | 7.25 | 33.00 | -- |
| Xvivo Perfusion AB | 72.74m | 9.84m | 590.26m | 193.00 | 60.36 | 3.19 | 33.84 | 8.11 | 3.51 | 3.51 | 26.04 | 66.41 | 0.3532 | 0.9342 | 4.61 | 4,331,195.00 | 4.78 | 3.04 | 5.18 | 3.26 | 74.87 | 73.74 | 13.53 | 10.86 | 3.13 | -- | 0.0503 | 0.00 | 37.63 | 30.08 | 87.52 | 103.46 | 18.21 | -- |
| Surgical Science Sweden AB | 83.66m | 12.47m | 679.69m | 336.00 | 54.50 | 1.72 | 37.41 | 8.12 | 2.77 | 2.77 | 18.55 | 87.73 | 0.1921 | 1.68 | 7.20 | 3,454,507.00 | 2.86 | 3.91 | 3.03 | 4.18 | 68.37 | 68.94 | 14.91 | 21.55 | 3.25 | -- | 0.0004 | 0.00 | 0.1398 | 54.17 | -43.73 | 59.89 | 39.76 | -- |
| Revenio Group Oyj | 105.92m | 19.10m | 731.06m | 246.00 | 38.26 | 6.51 | 29.98 | 6.90 | 0.7161 | 0.7161 | 3.97 | 4.21 | 0.7604 | 2.99 | 7.06 | 439,489.60 | 13.78 | 14.11 | 15.92 | 17.53 | 71.04 | 70.96 | 18.12 | 20.61 | 2.18 | 24.43 | 0.1018 | 53.12 | 7.19 | 15.91 | -3.20 | 14.64 | 22.93 | 5.92 |
| Arjo AB (publ) | 995.63m | 38.01m | 789.85m | 7.00k | 22.27 | 1.27 | 5.83 | 0.7933 | 1.58 | 1.58 | 41.36 | 27.67 | 0.7186 | 4.64 | 6.54 | 1,570,333.00 | 2.74 | 3.58 | 3.72 | 5.45 | 43.46 | 43.97 | 3.81 | 5.35 | 0.8874 | 4.96 | 0.431 | 44.32 | 2.84 | 4.82 | 3.75 | 4.32 | -12.31 | 7.89 |
| RaySearch Laboratories AB (publ) | 111.95m | 19.77m | 924.87m | 422.00 | 56.06 | 13.59 | 24.00 | 8.26 | 6.52 | 6.52 | 36.93 | 26.89 | 0.6144 | 8.17 | 3.14 | 3,044,546.00 | 10.85 | 2.96 | 16.36 | 4.37 | 91.88 | 90.93 | 17.66 | 5.80 | 1.52 | 217.60 | 0.3277 | 67.90 | 16.62 | 9.96 | 149.49 | 32.19 | 0.5132 | -- |
| Biotage AB | 173.33m | 22.54m | 1.01bn | 622.00 | 44.90 | 2.97 | 26.30 | 5.83 | 3.18 | 3.18 | 24.48 | 48.05 | 0.398 | 1.66 | 7.44 | 2,913,819.00 | 5.18 | 8.47 | 5.86 | 9.93 | 62.62 | 61.62 | 13.00 | 15.07 | 1.56 | 24.71 | 0.0583 | 48.01 | 9.83 | 13.30 | 15.45 | 8.74 | 30.04 | -- |
Data as of Jul 18 2025. Currency figures normalised to Revenio Group Oyj's reporting currency: Euro EUR
19.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Jul 2025 | 854.80k | 3.20% |
| Keskin�inen El�kevakuutusyhti� Ilmarinenas of 31 Dec 2023 | 699.79k | 2.62% |
| Swedbank Robur Fonder ABas of 30 May 2025 | 689.00k | 2.58% |
| SEB Wealth Management Finland Ltd.as of 30 May 2025 | 611.04k | 2.29% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 30 Apr 2025 | 596.93k | 2.24% |
| Keskin�inen Ty�el�kevakuutusyhti� Eloas of 31 Dec 2023 | 386.00k | 1.45% |
| Groupama Asset Management SAas of 31 Jan 2025 | 356.52k | 1.34% |
| S-Bank Fund Management Ltd.as of 31 Dec 2024 | 339.33k | 1.27% |
| Evli Fund Management Co. Ltd.as of 30 Jun 2025 | 335.42k | 1.26% |
| Handelsbanken Fonder ABas of 30 Jun 2025 | 318.74k | 1.20% |
More ▼
Data from 31 Mar 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
